Brief: Moleculin Biotech Files Prospectus For Resale Of Common Stock - SEC Filing
19/09/2025 22:30
Sept 19 (Reuters) - SEC Filing: MOLECULIN BIOTECH INC- FILES PROSPECTUS FOR RESALE, FROM TIME TO TIME, BY SELLING STOCKHOLDERS OF UP TO 64.9 MILLION SHARES OF COMMON STOCK - SEC FILING Source text: [ID:n0001437749-25-029526] Further company coverage: MBRX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Moleculin Biotech
See all newsMoleculin Biotech Inc reports results for the quarter ended September 30 - Earnings Summary
Brief: Moleculin Secures Australian Patent For Annamycin Formulation Technology
Moleculin Biotech Inc expected to post a loss of $8.87 a share - Earnings Preview
Brief: Moleculin Biotech Completes Dosing In Part A Of Miracle Trial Data Readout On Track For Q1 2027
NASDAQ RESUMED AT 09:00 AM